Alan Leonard Smith
Insider
First SEC filing: March 18, 2024 · Latest: March 18, 2024
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | IVZ | A | 8,641 | · | · | 18,338 Direct | +89.11% | Acquired | (price as of 2026-10-02) |
| March 13, 2026 | IVZ | F | 3,849 | $23.00 | $88,527 | 14,489 Direct | -20.99% | Disposed | 33.3% (price as of 2026-10-02) |
| March 13, 2026 | IVZ | M | 8,641 | · | · | 8,641 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2026 | IVZ | A | 8,936 | · | · | 13,711 Direct | +187.14% | Acquired | (price as of 2026-10-02) |
| Feb. 28, 2026 | IVZ | F | 4,014 | $26.26 | $105,408 | 9,697 Direct | -29.28% | Disposed | 16.8% (price as of 2026-10-02) |
| Feb. 28, 2026 | IVZ | M | 8,936 | · | · | 26,808 Direct | -25.00% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2026 | IVZ | A | 32,202 | · | · | 32,202 Direct | · | Acquired | (price as of 2026-10-02) |
| March 15, 2025 | IVZ | A | 8,641 | · | · | 8,641 Direct | · | Acquired | (price as of 2026-10-02) |
| March 15, 2025 | IVZ | F | 3,866 | $15.28 | $59,072 | 4,775 Direct | -44.74% | Disposed | 100.7% (price as of 2026-10-02) |
| March 15, 2025 | IVZ | M | 8,641 | · | · | 17,282 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2025 | IVZ | A | 35,744 | · | · | 35,744 Direct | · | Acquired | (price as of 2026-10-02) |
| March 15, 2024 | IVZ | A | 25,923 | · | · | 25,923 Direct | · | Acquired | (price as of 2026-10-02) |
| March 1, 2024 | CRBD | F | 2,668 | $24.50 | $65,366 | 66,740 Direct | -3.84% | Disposed | -15.0% (price as of 2026-10-02) |
| March 1, 2023 | CRBD | F | 2,176 | $20.22 | $43,999 | 69,408 Direct | -3.04% | Disposed | 3.0% (price as of 2026-10-02) |
| Feb. 21, 2023 | CRBD | A | 12,155 | · | · | 12,155 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2023 | CRBD | A | 10,583 | · | · | 71,584 Direct | +17.35% | Acquired | (price as of 2026-10-02) |
| Jan. 31, 2023 | CRBD | F | 16,428 | $21.39 | $351,395 | 61,001 Direct | -21.22% | Disposed | -2.7% (price as of 2026-10-02) |
| Sept. 14, 2022 | CRBD | A | 77,429 | · | · | 77,429 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 13, 2026 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 8,641 | Disposed |
| Feb. 28, 2026 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 8,936 | Disposed |
| Feb. 28, 2026 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 32,202 | Acquired |
| March 15, 2025 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 8,641 | Disposed |
| Feb. 28, 2025 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 35,744 | Acquired |
| March 15, 2024 | IVZ | Restricted Stock Units [F1] | Common Shares | $0.00 | · | 25,923 | Acquired |
| Feb. 21, 2023 | CRBD | Options (Rights to Buy) | Common Stock | $20.30 | Feb. 21, 2033 | 12,155 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 18, 2024 | IVZ | Common Shares | 0 | Direct |